Professor Chen Keneng: Esophageal and Lung Cancer Surgeon in Beijing

Professor Chen Keneng: Esophageal and Lung Cancer Surgeon in Beijing

Professor Chen Keneng: Thoracic Cancer Surgery Specialist

Professor Chen Keneng is a senior thoracic surgical oncologist, professor, and doctoral supervisor at Peking University Cancer Hospital. His clinical and academic work focuses on esophageal cancer, lung cancer, minimally invasive thoracic surgery, perioperative treatment, and multidisciplinary cancer care.

International patients can learn more about the hospital, imaging and pathology requirements, and treatment planning in our Peking University Cancer Hospital international patient guide.

Clinical Specialties

  • esophageal cancer;
  • gastroesophageal junction cancer;
  • early and locally advanced lung cancer;
  • minimally invasive thoracic surgery;
  • lymph-node assessment and dissection;
  • treatment before and after surgery;
  • complex or repeat thoracic operations; and
  • second opinions on surgical eligibility.

Esophageal Cancer

Esophageal cancer may cause difficulty swallowing, pain with swallowing, weight loss, chest discomfort, anemia, or persistent cough. The principal histological types are squamous-cell carcinoma and adenocarcinoma, and their distribution and treatment can differ.

Staging may include endoscopy with biopsy, contrast-enhanced CT, endoscopic ultrasound, PET-CT, bronchoscopy for selected upper tumors, and nutrition assessment. The relationship of the tumor to the airway, aorta, stomach, and lymph nodes is especially important.

Esophagectomy

Esophagectomy removes the affected esophagus and reconstructs the digestive passage, commonly using the stomach. It is a major operation with risks involving the lungs, heart, anastomosis, nerves, nutrition, and swallowing.

Open, minimally invasive, or hybrid approaches may be considered. The safest appropriate technique depends on tumor location and stage, previous treatment, anatomy, lung and heart function, and the surgical team’s experience.

Perioperative Treatment

Many patients with locally advanced esophageal cancer receive chemotherapy, chemoradiotherapy, immunotherapy in selected protocols, or another planned treatment before surgery. Postoperative treatment may depend on pathology and response.

The sequence should be agreed by a multidisciplinary team. Surgery alone is not always the strongest strategy, while not every patient benefits from an operation after systemic or radiation treatment.

Lung Cancer Surgery

For localized non-small cell lung cancer, surgery may involve wedge resection, segmentectomy, lobectomy, sleeve resection, or pneumonectomy. The extent depends on tumor size and location, lymph nodes, pulmonary reserve, and the need to preserve lung function.

Small peripheral cancers may be suitable for segmentectomy in selected cases. More complex central tumors can require airway or blood-vessel reconstruction to avoid removing an entire lung.

Minimally Invasive Thoracic Surgery

Video-assisted and robotic techniques can reduce incision size and may support faster recovery for suitable patients. Minimally invasive surgery should still achieve appropriate margins, lymph-node evaluation, and safe control of major structures.

Conversion to open surgery can be the safest decision when bleeding, adhesions, anatomy, or tumor involvement makes minimally invasive completion unsafe.

Who May Consider a Consultation?

  • patients with newly diagnosed esophageal or localized lung cancer;
  • patients needing a second opinion on whether surgery is appropriate;
  • patients comparing open, thoracoscopic, or robotic approaches;
  • patients with locally advanced disease needing treatment sequencing;
  • patients with reduced lung function or complex anatomy;
  • patients requiring repeat or salvage thoracic surgery review;
  • patients with conflicting staging or pathology; or
  • patients seeking multidisciplinary planning before a major operation.

Medical Records to Prepare

  • a concise medical summary and treatment timeline;
  • contrast-enhanced chest and abdominal CT in original DICOM format;
  • PET-CT, brain MRI, endoscopy, and endoscopic ultrasound when available;
  • pathology reports, glass slides, and paraffin blocks;
  • pulmonary-function tests and cardiac assessment;
  • bronchoscopy reports for selected tumors;
  • chemotherapy and radiotherapy details with response imaging;
  • previous thoracic operative notes;
  • recent blood tests and nutritional assessment; and
  • a clear list of questions about surgical extent, risks, and recovery.

Planning an International Consultation

Before traveling, patients should confirm whether imaging and pathology can be reviewed and whether additional staging is required. Remote medical-record review requires physician authorization. Final surgical eligibility, approach, timing, hospital stay, and cost require complete assessment by the treating team.

How CMCS Can Assist

CMCS – China Medical Concierge Shanghai is an independent medical concierge and health management company, not a hospital. We assist international patients with organizing and translating oncology records, identifying an appropriate specialist, requesting appointment availability, arranging interpretation, and planning medical travel in China.

Access to Professor Chen, remote review, surgery, or a particular treatment is subject to the doctor’s and hospital’s approval. CMCS does not guarantee appointments, surgical eligibility, or clinical outcomes.

Important Note

Doctor roles, surgical techniques, treatment availability, and appointment arrangements may change. This profile is for general information only and does not replace assessment by a qualified thoracic oncology team.

댓글 0개

댓글 남기기